These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. GLP-1 receptor is expressed in human stomach mucosa: analysis of its cellular association and distribution within gastric glands. Broide E; Bloch O; Ben-Yehudah G; Cantrell D; Shirin H; Rapoport MJ J Histochem Cytochem; 2013 Sep; 61(9):649-58. PubMed ID: 23803499 [TBL] [Abstract][Full Text] [Related]
4. Decreased Hypothalamic Glucagon-Like Peptide-1 Receptor Expression in Type 2 Diabetes Patients. Ten Kulve JS; van Bloemendaal L; Balesar R; IJzerman RG; Swaab DF; Diamant M; la Fleur SE; Alkemade A J Clin Endocrinol Metab; 2016 May; 101(5):2122-9. PubMed ID: 26672638 [TBL] [Abstract][Full Text] [Related]
5. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells. Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053 [TBL] [Abstract][Full Text] [Related]
6. The incretin system and its role in type 2 diabetes mellitus. Holst JJ; Vilsbøll T; Deacon CF Mol Cell Endocrinol; 2009 Jan; 297(1-2):127-36. PubMed ID: 18786605 [TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-1 (GLP-1) reduces mortality and improves lung function in a model of experimental obstructive lung disease in female mice. Viby NE; Isidor MS; Buggeskov KB; Poulsen SS; Hansen JB; Kissow H Endocrinology; 2013 Dec; 154(12):4503-11. PubMed ID: 24092637 [TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 colon cancer cells. Koehler JA; Kain T; Drucker DJ Endocrinology; 2011 Sep; 152(9):3362-72. PubMed ID: 21771884 [TBL] [Abstract][Full Text] [Related]
9. Fractionated whole body gamma irradiation modulates the hepatic response in type II diabetes of high fat diet model rats. Khalil A; Al-Daoude A Mol Biol Rep; 2019 Apr; 46(2):2273-2283. PubMed ID: 30747384 [TBL] [Abstract][Full Text] [Related]
10. An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis. Baggio LL; Huang Q; Cao X; Drucker DJ Gastroenterology; 2008 Apr; 134(4):1137-47. PubMed ID: 18313669 [TBL] [Abstract][Full Text] [Related]
11. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. Theodorakis MJ; Carlson O; Michopoulos S; Doyle ME; Juhaszova M; Petraki K; Egan JM Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E550-9. PubMed ID: 16219666 [TBL] [Abstract][Full Text] [Related]
12. The pharmacologic basis for clinical differences among GLP-1 receptor agonists and DPP-4 inhibitors. Morales J Postgrad Med; 2011 Nov; 123(6):189-201. PubMed ID: 22104467 [TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis. Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271 [TBL] [Abstract][Full Text] [Related]
16. Agonist-induced internalisation of the glucagon-like peptide-1 receptor is mediated by the Gαq pathway. Thompson A; Kanamarlapudi V Biochem Pharmacol; 2015 Jan; 93(1):72-84. PubMed ID: 25449603 [TBL] [Abstract][Full Text] [Related]
17. GLP-1-based strategies: a physiological analysis of differential mode of action. Burcelin R; Gourdy P; Dalle S Physiology (Bethesda); 2014 Mar; 29(2):108-21. PubMed ID: 24583767 [TBL] [Abstract][Full Text] [Related]
18. Role of the incretin pathway in the pathogenesis of type 2 diabetes mellitus. Freeman JS Cleve Clin J Med; 2009 Dec; 76 Suppl 5():S12-9. PubMed ID: 19952298 [TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice. Kissow H; Hartmann B; Holst JJ; Viby NE; Hansen LS; Rosenkilde MM; Hare KJ; Poulsen SS Regul Pept; 2012 Nov; 179(1-3):91-100. PubMed ID: 22989472 [TBL] [Abstract][Full Text] [Related]
20. Beyond glucose lowering: glucagon-like peptide-1 receptor agonists, body weight and the cardiovascular system. Vergès B; Bonnard C; Renard E Diabetes Metab; 2011 Dec; 37(6):477-88. PubMed ID: 21871831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]